Cardiovascular effects of melatonin receptor agonists

Author： Paulis Ludovit Simko Fedor Laudon Moshe

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.11, 2012-11, pp. : 1661-1678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational melatonin receptor agonists

By Hardeland Rüdiger

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite

Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons

By Ying S.-W. Rusak B. Mocaer E.

European Journal of Pharmacology, Vol. 342, Iss. 1, 1998-01 ,pp. : 29-37

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of melatonin receptor agonists and antagonists

By Dubocovich M.L.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 153-173

Informa Healthcare

Access to resources Recommend Favorite

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-07 ,pp. : 954-968

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Substituted Phenylpropylamides as Highly Selective Agonists at the Melatonin MT2 Receptor

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 289-300

Bentham Science Publishers

Access to resources Recommend Favorite